🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
1. Primary Objective To assess the response rate of sequential VAD (Vincris...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2006-03
Trial ID
NCT00378755
Treatments Being Tested
Phase II multicenter pilot trial (073) evaluating tandem HDT with PBSC supp...
Status
Completed
Location
Emmanuel Gyan
Start Date
1994-10
Trial ID
NCT00869284
A prospective pilot trial was proposed to patients with DLBCL, with IH or h...
Status
Completed
Location
University Hospital
Start Date
2002-04
Trial ID
NCT00965289
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of brentuximab...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2014-10-10
Trial ID
NCT02227199
Treatments Being Tested
This is a feasibility study to determine optimal thigh cuff design using a ...
Status
Completed
Location
John Wayne Cancer Institute at Providence Saint John's Health Center
Start Date
2017-01-01
Trial ID
NCT03097523
Treatments Being Tested
This is a phase I, double-blind, placebo-controlled,dose-ranging clinical t...
Status
Unknown
Location
Hospital da Bahia
Start Date
2022-01-13
Trial ID
NCT04844268
A prospective Phase II clinical study to assess the efficacy and toxicity o...
Status
Completed
Location
HELIOS Klinik Berlin-Buch, Klinik für Hämatologie und Stammzelltransplantation
Start Date
2019-06-24
Trial ID
NCT04121507
This research is testing whether the investigational drug isatuximab is saf...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2021-07-13
Trial ID
NCT04653246
Treatments Being Tested
This study aims to measure the effect of a structured AAT session with a tu...
Status
Recruiting
Location
Igdır University
Start Date
2026-03-01
Trial ID
NCT07439289
Treatments Being Tested
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested